Stada has lined up a new independent chairman and board of directors in a key step for the private equity-backed German drug ...

J.P. Morgan releases its annual look-ahead days before the entire biopharma industry descends on San Francisco for the annual ...

President-elect Donald Trump threatened Tuesday to place new tariffs on imports from Denmark unless the country gives up control of Greenland, news that dented the stocks of some of Denmark's most ...

Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.

A Danish team thinks it can aid rAAV manufacturers, who may not be able to spend three to five years working on a project ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Poor nutrition during pregnancy can have serious consequences for both maternal and child health. A new research collaboration – 'Mother's Micronutrient Supplement for Pregnancy and Lactation' (MoMS) ...

Novo Nordisk's U.S.-listed and domestic shares rose Wednesday after analysts from UBS upgraded the Danish drugmaker's stock ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 484.89% and ...